Expert Approaches to the Treatment and Management of Psoriasis

A continuing medical education activity provided by NAMCP and AAMCN

This activity is an archive from the live session from the 2022 Fall Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from January 1, 2023, to March 1, 2024

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by educational grants from
Arcutis Biotherapeutics and Bristol Myers and Squibb

Description:
Psoriasis is a complex, chronic, immune-mediated inflammatory disease that affects approximately 7 million of the population in the United States. Psoriasis is a periodic flare-up of sharply defined red patches, covered by a silvery, flaky surface. The main disease activity leading to psoriasis occurs in the epidermis, the top five layers of the skin. The disease most commonly appears on the skin of the scalp, elbow, knees, and lumbosacral areas of the body. Many of the patients are not receiving the appropriate treatment discussed in the current guidelines and standards of care. Psoriasis is a complex disease to manage, but the goal should be a patient-centered treatment that reduces disease burden, improves on quality-of-life, and addresses the risks of systemic complications and comorbid conditions. The under diagnosis and treatment of psoriasis continues to be a serious concern.

Upon completion of this activity, participants will be able to:

  • Discuss the latest developments in the treatment and management of psoriasis, including a close look at new data and guidelines recommendations

  • Explore diagnostic updates of various stages of psoriasis and how this relates to both drug development and use of traditional and modern therapeutic options

  • Assess key clinical trial data for novel and emerging therapies intended to improve symptoms, and slow or prevent progression of psoriasis

  • Discuss personalized treatment plans for psoriasis by using patient-provider shared decision-making opportunities

     

Faculty: Paul Yamauchi, MD, PhD
Clinical Assistant Professor of Dermatology
David Geffen School of Medicine at UCLA
Adjunct Associate Professor, John Wayne Cancer Institute

Disclosure:

(Relevant Financial Relationships with Ineligible Companies in the Last 24 Months):
Dr. Yamauchi has served on an advisory board for Amgen, ChemoCentryx, Dermira, and Lilly. He has served as a consultant for AbbVie, Amgen, Arcutis, Inc, Celgene, Dermavant Sciences, Janssen, Leo Pharma, Menlo Therapeutics, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sun Pharmaceuticals, and UCB. He has received grant/research support from AbbVie, Akros, Amgen, AnaptysBio, Arcutis, Inc, Boehringer Ingelheim, Botanix Pharmaceuticals, Bristol Myers Squibb, Celgene, Dermavant, Dermira, Escalier, Galderma, Galapagos, Genentech, Glenmark, Hovione, Incyte, Janssen, Kiniksa, Leo Pharma, Lilly, MedImmune, Menlo Therapeutics, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sandoz, Sol-Gel Technologies, Sun Pharmaceuticals, UCB, and Vanda. He has served on the speaker's bureau for AbbVie, Almirall, Amgen, Celgene, Dermira, Janssen, Leo Pharma, Lilly, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, Sun Pharmaceuticals, and UCB. His presentation has been reviewed for any bias.
Planning Committee: Bill Williams, MD has no relevant financial relationships with an ineligible company in the last 24 months to disclose.

Jeremy Williams has no relevant financial relationships with an ineligible company in the last 24 months to disclose.

Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships with an ineligible company in the last 24 months to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by educational grants from
Arcutis Biotherapeutics and Bristol Myers and Squibb

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue